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Isolation and identification of Non fermentor GNB and detection of bla VIM mediated 
carbapenamase resistance from clinical isolates in a Teriatary care Hospital 
 
Introduction 
                 Non fermenter Gram negative bacilli were considered as contaminants or 
commensals of little significance1.   However, recent literature review shows that these 
organisms are now associated with life-threatening infections such as septicemia, pneumonia, 
urinary tract infection, meningitis, surgical site infection, ventilator associated pneumonia 
(VAP), wound infection, osteomyelitis etc. They account for around 15% of all bacterial isolates 
from clinical samples1   Pseudomonas and Acinetobacter species together accounted for 84.06% 
of NFGNB. Carbapenemases are diverse enzymes that vary in their ability to hydrolyze 
carbapenems and other beta‑ lactams. Detection of carbapenemase is a crucial infection control 
issue because they are often associated with extensive antibiotic resistance, treatment failures 
and infection‑  associated mortality5..  This study focuses on the detection of carbapenemase and 
metallo-β-lactamase production in clinical isolates of  Non Fermentor Gram negative bacilli. 
Aims and objectives: 
 To isolate and identify Non fermentor Gram negative bacilli from clinical specimens. 
 To determine the Antibiogram of identified non fermenting gram negative bacilli .  
 To detect the production of carbapenemase by non fermenting gram negative bacilli using 
phenotypic methods. 
 To detect the presence of metallo betalactamse using bla VIM gene by Real time PCR 
 
Materials and Methods: 
The study was carried out in the department of Microbiology, Tirunelveli Medical 
College. A total of 100 isolates of Non Fermenter Gram Negative Bacilli were isolated from 
specimens of respiratory tract infection, wound infection, urinary tract infections, septicaemia, 
post operative wound infections, ear infections satisfying both inclusion and exclusion criteria. 
The isolated NFGNB were subjected to meropenem resistance by disc diffusion test and Those 
strains which show resistance to meropenam will be subjected to Carbapenamase detection 
method by using , Double disc synergy test , combination disc method and  MBL E test. bla VIM 
gene responsible for metallobeta lactamase production is detected for the resistant isolates by 
performing Real time PCR 
Results  
Among the 100 non fermenter isolates, 87 were Pseudomonas aeruginosa and 13 were 
Acinetobacter baumanii. Maximum number NFGNB were from the male patients(62%) and they 
were  in the age group of 40 -50(25%). More number of NFGNB were from Medical 
ward(41.4%) and the they were maximally isolated from pus(37%) . Screening with meropenem 
disk showed 32% of isolates were positive for  carbapenem resistance. Among them CDT 
detected 59.3% ,  DDST  50% and E test 46.8% of  theMBL producer. MDR NFGNB were 13  
and MBL producers were 5 among the 32 isolates. 11 % of the isolates were positive for bla 
VIM gene by real time PCR. 
Conclusion  
The proper identification of NFGNB up to the species level together with monitoring their 
susceptibility patterns are mandatory for proper management of infections caused by these 
pathogens. The antibiotic susceptibility patterns may change with time and may vary from 
hospital to hospital. Metallo-β-lactamases are one of the most worrisome resistance mechanisms 
because in addition to limiting treatment options, their genes are carried on highly mobile 
elements, allowing easy dissemination . Rapid detection of MBLs is essential. This could help to 
modify therapy and to initiate effective infection control to prevent further dissemination . 
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